Cite
HARVARD Citation
Gupta, P. et al. (2016). PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia. Cancer letters. 383 (2), pp. 220-229. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gupta, P. et al. (2016). PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia. Cancer letters. 383 (2), pp. 220-229. [Online].